137 D. INJURY › 5. CONCLUSION ON INJURY, Decision_act (EU) 2012/343

In forcesince 27 Jun 2012

It is noted in this regard that each case has to be judged on its own merits. In this particular case, the investigation not only established clear signs of recovery of the Union industry towards the end of the period considered, but also the magnitude of the negative trends was relatively limited. For example the market share of the Union industry remained stable and relatively high overall, capacity utilisation fell slightly but remained at a level above 80 %, and investments increased. By contrast, in Oxalic acid [OJ L 106, 18.4.2012, p. 1.] there was, for instance, a loss of Union industry market share of 9 % in the IP compared with the first year of the injury investigation period [See Commission Regulation (EU) No 1043/2011 imposing provisional duties (OJ L 275, 20.10.2011, p. 1), recital 77.]. In Citric acid [OJ L 323, 3.12.2008, p. 1.] there was a similar loss of market share and there was a decrease of investments [See Commission Regulation (EC) No 488/2008 imposing provisional duties (OJ L 143, 3.6.2008, p. 13), at respectively recitals 68 and 72.].

  • celex=32008R0488
  • celex=32011R1043